Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
Strongbridge Biopharma PLC obtained US and Canadian rights to Macrilen (macimorelin) from AEterna Zentaris Inc. on Jan. 17,...








